List of Tables
Table 1. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Competitive Situation by Manufacturers in 2025
Table 4. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Manufacturers (2021–2026)
Table 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market T-Cell & NK-Cell Engaging Bispecific Antibodies Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of T-Cell & NK-Cell Engaging Bispecific Antibodies, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies, Product Types and Applications
Table 12. Global Key Manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Companies by Tier (Tier 1, Tier 2, Tier 3), based on T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (K Units), 2021–2026
Table 18. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Region (2021–2026)
Table 19. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (K Units), 2027–2032
Table 20. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Region (2027–2032)
Table 21. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region (US$ Million), 2021–2026
Table 22. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Region (2021–2026)
Table 23. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region (US$ Million), 2027–2032
Table 24. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Region (2027–2032)
Table 25. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (K Units), 2021–2026
Table 27. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (K Units), 2027–2032
Table 28. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (US$ Million), 2021–2026
Table 29. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (US$ Million), 2027–2032
Table 30. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (K Units), 2021–2026
Table 32. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (K Units), 2027–2032
Table 33. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (US$ Million), 2021–2026
Table 34. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (K Units), 2021–2026
Table 42. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (K Units), 2027–2032
Table 43. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (US$ Million), 2027–2032
Table 50. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) by Type (2021–2026)
Table 51. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) by Type (2027–2032)
Table 52. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2021–2026)
Table 53. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2027–2032)
Table 54. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$ Million) by Type (2021–2026)
Table 55. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$ Million) by Type (2027–2032)
Table 56. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Type (2021–2026)
Table 57. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Type (2027–2032)
Table 58. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/Unit) by Type (2021–2026)
Table 59. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/Unit) by Type (2027–2032)
Table 60. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) by Application (2021–2026)
Table 61. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) by Application (2027–2032)
Table 62. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2021–2026)
Table 63. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2027–2032)
Table 64. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$ Million) by Application (2021–2026)
Table 65. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$ Million) by Application (2027–2032)
Table 66. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Application (2021–2026)
Table 67. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Application (2027–2032)
Table 68. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/Unit) by Application (2021–2026)
Table 69. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/Unit) by Application (2027–2032)
Table 70. Amgen Company Information
Table 71. Amgen Description and Business Overview
Table 72. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 74. Amgen Recent Developments/Updates
Table 75. Immunocore Company Information
Table 76. Immunocore Description and Business Overview
Table 77. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 79. Immunocore Recent Developments/Updates
Table 80. Johnson & Johnson Company Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Roche Company Information
Table 86. Roche Description and Business Overview
Table 87. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 89. Roche Recent Developments/Updates
Table 90. Pfizer Company Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 94. Pfizer Recent Developments/Updates
Table 95. AbbVie Company Information
Table 96. AbbVie Description and Business Overview
Table 97. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 99. AbbVie Recent Developments/Updates
Table 100. MacroGenics Company Information
Table 101. MacroGenics Description and Business Overview
Table 102. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 104. MacroGenics Recent Developments/Updates
Table 105. Regeneron Company Information
Table 106. Regeneron Description and Business Overview
Table 107. Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 109. Regeneron Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors List
Table 113. T-Cell & NK-Cell Engaging Bispecific Antibodies Customers List
Table 114. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Trends
Table 115. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Drivers
Table 116. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Challenges
Table 117. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of T-Cell & NK-Cell Engaging Bispecific Antibodies
Figure 2. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Value by Type (US$ Million), 2021–2032
Figure 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Type: 2025 & 2032
Figure 4. T-Cell Engagers Product Picture
Figure 5. NK-Cell Engagers Product Picture
Figure 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Value by Application (US$ Million), 2021–2032
Figure 7. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Application: 2025 & 2032
Figure 8. Hematological Cancers
Figure 9. Solid Tumors
Figure 10. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size (US$ Million), 2021–2032
Figure 12. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), 2021–2032
Figure 13. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Average Price (US$/Unit), 2021–2032
Figure 14. T-Cell & NK-Cell Engaging Bispecific Antibodies Report Years Considered
Figure 15. T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Manufacturers in 2025
Figure 16. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Players: Market Share by Revenue in T-Cell & NK-Cell Engaging Bispecific Antibodies in 2025
Figure 18. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Country (2021–2032)
Figure 21. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Country (2021–2032)
Figure 22. United States T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Country (2021–2032)
Figure 25. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Country (2021–2032)
Figure 26. Germany T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Region (2021–2032)
Figure 33. China T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Indonesia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Thailand T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Malaysia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Country (2021–2032)
Figure 43. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Country (2021–2032)
Figure 44. Mexico T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Country (2021–2032)
Figure 49. Turkey T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of T-Cell & NK-Cell Engaging Bispecific Antibodies by Type (2021–2032)
Figure 53. Global Revenue Market Share of T-Cell & NK-Cell Engaging Bispecific Antibodies by Type (2021–2032)
Figure 54. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of T-Cell & NK-Cell Engaging Bispecific Antibodies by Application (2021–2032)
Figure 56. Global Revenue Market Share of T-Cell & NK-Cell Engaging Bispecific Antibodies by Application (2021–2032)
Figure 57. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/Unit) by Application (2021–2032)
Figure 58. T-Cell & NK-Cell Engaging Bispecific Antibodies Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
